LONDON (Alliance News) - LONDON (Alliance News) - Healthcare and pharmaceuticals giant GlaxoSmithKline PLC Monday said Executive Director Moncef Slaoui was allocated 17 American Depositary Shares at a price of USD51.54 each Friday. Glaxo shares were up 0.8% at 1,576.50 pence Monday. B Read More
LONDON (Alliance News) - UK banks are still counting the cost of their product mis-selling, with Lloyds Banking Group Monday adding a further GBP1.93 billion to the amount it has set aside to cover claims for previous sales of payment protection insurance and interest rate hedging products. <p Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.<br /><br />-------<br /><br /><strong>FTSE 100 - WINNERS</strong><br /><br /><strong>Randgold Resources</strong>, up 2.1%. In a difficult environment for gold miners, Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that it had received Breakthrough Therapy designation for its bone marrow disorder treatment Promacta/Revolade from the US Food and Drug Administration. The treatment is designed for patients with severe aplastic anemia, a rare disord Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that it had received Breakthrough Therapy designation for its bone marrow disorder treatment Promacta/Revolade from the US Food and Drug Administration. The treatment is designed for patients with severe aplastic anemia, a rare disord Read More
LONDON (Alliance News) - GlaxoSmithKline PLC will this week announce plans to launch late stage clinical trials on ten new drugs over the next two years, the Daily Telegraph reported Monday, without saying where it got the information. The list will include medicines in Glaxo?s key areas of Read More
LONDON (Alliance News) - Sinclair IS Pharma PLC said Friday that it had acquired dermal filler Atlean from GlaxoSmithKline PLC's dermatology business Stiefel. The company said that Atlean, used to reduce wrinkles, will complement its existing facial care brands Sculptra and Perfectha. Atlea Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that its Phase III study of the combination treatment of Tafinlar and Mekinist for the treatment of metastatic melenoma had reached its primary endpoint. The company said the response rate and interim overall survival results in the s Read More
LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process.<br /><br />In a speech at the World Ec Read More
LONDON (Alliance News) - The following is a summary of top news stories Friday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Royal Mail</strong> PLC reported a 2% increase in like-for-like revenues for the first half of the year, driven by further growth in its Read More
LONDON (Alliance News) - Pharmaceuticals giant GlaxoSmithKline PLC said Friday that it had received a recommendation for marketing authorisation for its Eperzan treatment for type 2 diabetes from the European Medicines Agency's Committee for Medical Products for Human Use. The recommendatio Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />KEPLER CHEUVREUX STARTS BP WITH 'BUY' - PRICE TARGET 545 PENCE <br />----------<br />KEPLER CHEUVREUX STARTS BG GROUP WITH 'HOLD Read More
LONDON (Alliance News) - UK shares have opened higher Friday, as Bank of England Governor Mark Carney backed off of forward guidance and said there is "no immediate need" to raise interest rates.<br /><br /><strong>Royal Mail</strong> has reported a 2% increase in like-for-like revenues for th Read More
(An item published at 1259 GMT misstated the market prices. The correct version follows.) LONDON (Alliance News) - Anglo-Dutch consumer goods and food giant<strong> Unilever</strong> Tuesday kicked off the latest UK earnings season, reporting lower revenues for the fourth quarter and who Read More